Comments
Loading...
Tactile Systems Tech Insider Trading Activity | NASDAQ:TCMD | Benzinga
Track the latest Tactile Systems Tech insider trading activity. Stay informed on recent buys, sells, and market impact for Tactile Systems Tech stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Tactile Systems Technology Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 27, 2025, Elaine Birkemeyer, the company's CHIEF FINANCIAL OFFICER sold 2.07K shares for $14.51 each.
- On February 27, 2025, Kristie Burns, the company's SR. VP MKTG & CLINICAL AFFAIRS sold 6.47K shares for $14.4 each.
- On February 27, 2025, DANIEL REUVERS, the company's DIRECTOR sold 28.34K shares for $14.18 each.
Ownership Statistics for Tactile Systems Technology Inc
Shares Outstanding
23.666M
Insider Shares Owned
1.539M
Insider Percentage Owned
6.50%
Institutional Shares Held
10.755M
Institutional Percentage Held
45.4%
| Feb 27, 2025 | Elaine Birkemeyer | CHIEF FINANCIAL OFFICER | -2.07K | $14.51 | -$29.98K | SELL | -1.98% | 102.03K | Feb 25 | View |
| Feb 27, 2025 | Kristie Burns | SR. VP MKTG & CLINICAL AFFAIRS | -6.47K | $14.40 | -$93.16K | SELL | -7.70% | 77.54K | Feb 25 | View |
| Feb 27, 2025 | DANIEL REUVERS | DIRECTOR | -28.34K | $14.18 | -$401.85K | SELL | -11.66% | 214.60K | Feb 25 | View |
| Feb 24, 2025 | DANIEL REUVERS | DIRECTOR | 4.92K | $14.55 | -$159.15K | GRANT | 2.06% | 242.94K | Feb 20 - Feb 24 | View |
| Feb 24, 2025 | Kristie Burns | SR. VP MKTG & CLINICAL AFFAIRS | 19.24K | $14.65 | -$70.75K | GRANT | 29.70% | 84.01K | Feb 20 - Feb 24 | View |
| Feb 24, 2025 | Elaine Birkemeyer | CHIEF FINANCIAL OFFICER | 42.80K | $14.70 | -$55.54K | GRANT | 69.83% | 104.10K | Feb 20 - Feb 24 | View |
| Aug 14, 2024 | Lee Sherri Ferstler | SENIOR VP, SALES | -1.55K | $13.07 | -$20.26K | SELL | -3.84% | 38.76K | Aug 12 | View |
| May 20, 2024 | Elaine Birkemeyer | CHIEF FINANCIAL OFFICER | -3.04K | $13.68 | -$41.59K | SELL | -4.73% | 61.30K | May 16 | View |
| May 10, 2024 | WILLIAM BURKE | DIRECTOR | 7.97K | $14.06 | -$35.15K | GRANT | 28.69% | 35.74K | May 08 | View |
| May 08, 2024 | Kristie Burns | SR. VP MKTG & CLINICAL AFFAIRS | -815.00 | $14.37 | -$11.71K | SELL | -1.29% | 62.57K | May 06 | View |
| Feb 29, 2024 | Kristie Burns | SR. VP MKTG & CLINICAL AFFAIRS | -1.33K | $15.52 | -$20.71K | SELL | -2.06% | 63.39K | Feb 27 - Feb 29 | View |
| Feb 29, 2024 | DANIEL REUVERS | PRESIDENT AND CEO | -6.08K | $15.52 | -$94.44K | SELL | -2.49% | 238.03K | Feb 27 - Feb 29 | View |
| Feb 27, 2024 | DANIEL REUVERS | PRESIDENT AND CEO | 46.41K | $15.37 | -$178.50K | GRANT | 23.48% | 244.11K | Feb 23 - Feb 26 | View |
| Feb 27, 2024 | Kristie Burns | SR. VP MKTG & CLINICAL AFFAIRS | 7.50K | $15.32 | -$65.33K | GRANT | 13.39% | 63.51K | Feb 23 - Feb 26 | View |
| Aug 09, 2023 | DANIEL REUVERS | PRESIDENT AND CEO | -1.06K | $20.53 | -$21.81K | SELL | -0.84% | 125.65K | Aug 07 | View |
| May 16, 2023 | WILLIAM BURKE | DIRECTOR | -4.40K | $21.86 | -$96.18K | SELL | -13.68% | 27.77K | May 12 | View |
| May 10, 2023 | Kristie Burns | SR. VP MKTG & CLINICAL AFFAIRS | -786.00 | $18.65 | -$14.66K | SELL | -2.10% | 36.56K | May 08 | View |
| May 10, 2023 | ERIC PAULS | SENIOR VP, SALES | -550.00 | $18.55 | -$10.20K | SELL | -1.83% | 29.50K | May 08 | View |
| Mar 03, 2023 | Brent Moen | CHIEF FINANCIAL OFFICER | -1.39K | $14.10 | -$19.61K | SELL | -2.77% | 48.76K | Mar 01 | View |
| Feb 28, 2023 | DANIEL REUVERS | PRESIDENT AND CEO | -605.00 | $15.20 | -$107.72K | SELL | -0.48% | 126.72K | Feb 25 - Feb 28 | View |
| Feb 28, 2023 | Brent Moen | CHIEF FINANCIAL OFFICER | -1.75K | $15.32 | -$62.06K | SELL | -3.37% | 50.15K | Feb 25 - Feb 28 | View |
| Feb 28, 2023 | Kristie Burns | SR. VP MKTG & CLINICAL AFFAIRS | -1.33K | $15.34 | -$35.24K | SELL | -3.45% | 37.35K | Feb 25 - Feb 28 | View |
| Feb 28, 2023 | ERIC PAULS | SENIOR VP, SALES | -878.00 | $15.29 | -$22.52K | SELL | -2.84% | 30.05K | Feb 25 - Feb 28 | View |
| Aug 10, 2022 | DANIEL REUVERS | PRESIDENT AND CEO | -1.02K | $9.18 | -$9.36K | SELL | -1.35% | 74.71K | Aug 08 | View |
| Aug 08, 2022 | WILLIAM BURKE | DIRECTOR | 4.90K | $9.15 | $44.84K | BUY | 25.08% | 24.44K | Aug 04 | View |
| May 23, 2022 | WILLIAM BURKE | DIRECTOR | -1.10K | $10.12 | -$11.13K | SELL | -5.33% | 19.54K | May 19 | View |
| May 10, 2022 | Kristie Burns | SR. VP MKTG & CLINICAL AFFAIRS | -999.00 | $13.04 | -$13.02K | SELL | -4.35% | 21.96K | May 06 | View |
| May 10, 2022 | ERIC PAULS | SENIOR VP, SALES | -600.00 | $13.03 | -$7.82K | SELL | -3.17% | 18.30K | May 06 | View |
| Mar 09, 2022 | Brent Moen | CHIEF FINANCIAL OFFICER | -176.00 | $20.64 | -$3.63K | SELL | -0.34% | 51.90K | Mar 07 | View |
| Mar 03, 2022 | Brent Moen | CHIEF FINANCIAL OFFICER | -1.63K | $20.33 | -$33.18K | SELL | -3.04% | 52.08K | Mar 01 | View |
| Feb 28, 2022 | DANIEL REUVERS | PRESIDENT AND CEO | 53.06K | $19.78 | -$17.35K | GRANT | 234.08% | 75.73K | Feb 24 - Feb 28 | View |
| Feb 28, 2022 | Brent Moen | CHIEF FINANCIAL OFFICER | 28.50K | $19.84 | -$12.38K | GRANT | 113.08% | 53.71K | Feb 24 - Feb 28 | View |
| Aug 09, 2021 | DANIEL REUVERS | PRESIDENT AND CEO | -1.06K | $43.11 | -$45.83K | SELL | -4.48% | 22.67K | Aug 06 | View |
| Jul 07, 2021 | DANIEL REUVERS | PRESIDENT AND CEO | -2.96K | $49.75 | -$147.32K | SELL | -11.09% | 23.73K | Jul 07 | View |
| Jun 28, 2021 | WILLIAM BURKE | DIRECTOR | 1.00K | $37.31 | -$219.60K | SELL-OPTIONS | 13.27% | 8.53K | Jun 24 | View |
| May 17, 2021 | WILLIAM BURKE | DIRECTOR | -800.00 | $52.08 | -$41.66K | SELL | -13.69% | 5.04K | May 13 | View |
| Mar 09, 2021 | Brent Moen | CHIEF FINANCIAL OFFICER | -174.00 | $47.33 | -$8.23K | SELL | -0.67% | 25.69K | Mar 05 | View |
| Mar 09, 2021 | Bryan Rishe | SVP, SALES | -196.00 | $47.15 | -$9.24K | SELL | -0.52% | 37.57K | Mar 05 | View |
| Mar 02, 2021 | Brent Moen | CHIEF FINANCIAL OFFICER | 2.91K | $52.08 | -$117.45K | GRANT | 12.69% | 25.86K | Feb 25 - Feb 28 | View |
| Mar 02, 2021 | Bryan Rishe | SVP, SALES | -1.14K | $53.12 | -$180.75K | SELL | -2.94% | 37.76K | Feb 25 - Feb 28 | View |
| Jan 06, 2021 | WILLIAM BURKE | DIRECTOR | 0.00 | $27.57 | -$52.70K | SELL-OPTIONS | 0.00% | 5.84K | Jan 04 | View |
| Nov 04, 2020 | WILLIAM BURKE | — | 0.00 | $23.75 | -$41.25K | OPTION EXERCISE | 0.00% | 5.84K | Nov 02 | View |
| Jun 29, 2020 | Bryan Rishe | — | -2.33K | $40.66 | -$94.78K | SELL | -5.65% | 38.91K | Jun 25 | View |
| Jun 12, 2020 | Bryan Rishe | — | -2.33K | $44.77 | -$104.31K | SELL | -5.35% | 41.24K | Jun 10 | View |
| May 28, 2020 | Bryan Rishe | — | -2.33K | $50.10 | -$116.73K | SELL | -5.08% | 43.57K | May 26 | View |
| May 15, 2020 | WILLIAM BURKE | — | -550.00 | $49.94 | -$27.47K | SELL | -8.60% | 5.84K | May 13 | View |
| May 13, 2020 | Bryan Rishe | — | -2.33K | $49.22 | -$114.68K | SELL | -4.88% | 45.45K | May 11 | View |
| Apr 30, 2020 | Gerald Mattys | — | 53.00K | $28.32 | -$2.14M | OPTION EXERCISE | 19.50% | 324.79K | Apr 28 - Apr 29 | View |
| Apr 29, 2020 | Bryan Rishe | — | -2.33K | $52.66 | -$122.70K | SELL | -4.65% | 47.78K | Apr 27 | View |
| Apr 15, 2020 | Bryan Rishe | — | -2.33K | $47.26 | -$110.12K | SELL | -4.44% | 50.11K | Apr 13 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.